PROM1 and malignant colon neoplasm: We were able to detect CD133 staining in the majority (78%) of colon cancers analyzed although with a high heterogeneity in term of percentage of positive cells (range 0-80%) whose increase was associated with an increased risk of recurrence and death for the disease (Table2 and Figure3).